Evidence map›Paper›PMID 30983860›Full record

ArticleBioinformatics and biology insights2019

High-Throughput Analysis of Clinical Flow Cytometry Data by Automated Gating.

Hunjoong Lee, Yongliang Sun, Lisa Patti-Diaz, Michael Hedrick, Anka G Ehrhardt

Abstract read
In one paragraph

Article in Bioinformatics and biology insights, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. flowSim: Near duplicate detection for flow cytometry data.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2023
    Article
  8. Full spectrum flow cytometry and mass cytometry: A 32-marker panel comparison.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2022
    Article
  9. The role of CD8Clinical rheumatology · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Machine Learning of Discriminative Gate Locations for Clinical Diagnosis.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2020
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hunjoong LeeClinical Flow Cytometry, Translational Medicine, Bristol-Myers Squibb, Pennington, NJ, USA.
Yongliang SunClinical Flow Cytometry, Translational Medicine, Bristol-Myers Squibb, Pennington, NJ, USA.
Lisa Patti-DiazClinical Flow Cytometry, Translational Medicine, Bristol-Myers Squibb, Pennington, NJ, USA.
Michael HedrickClinical Flow Cytometry, Translational Medicine, Bristol-Myers Squibb, Pennington, NJ, USA.
Anka G EhrhardtClinical Flow Cytometry, Translational Medicine, Bristol-Myers Squibb, Pennington, NJ, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advancements in flow cytometers with capability to measure 15 or more parameters have enabled us to characterize cell populations at unprecedented levels of detail. Beyond discovery research, there is now a growing demand to dive deeper into evaluating the immune response in clinical trials for immune modulating compounds. However, for high-volume, complex flow cytometry data generated in clinical trials, conventional manual gating remains the standard of practice. Traditional manual gating is resource intense and becomes a bottleneck and an impractical method to complete high volumes of flow cytometry data analysis. Current efforts to automate "manual gating" have shown that computational algorithms can facilitate the analysis of daunting multi-parameter data; however, a greater degree of precision in comparison with traditional manual gating is needed for wide-scale adoption of automated gating methods. In an effort to more closely follow the manual gating process, our automated gating pipeline was created to include negative controls (Fluorescence Minus One [FMO]) to enhance the reliability of gate placement. We demonstrate that use of an automated pipeline, heavily relying on FMO controls for population discrimination, can analyze multi-parameter, large-scale clinical datasets with comparable precision and accuracy to traditional manual gating.

Indexed as

Automated gatingdata analysisdrug-developmentflow cytometry

Identifiers

PMID30983860
PMCPMC6448119

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.